loading

Finanzdaten der Solid Biosciences Inc-Aktie (SLDB)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
-
- - - -
Operating Expenses
20.65%
26.86
22.27 23.11 26.84 32.03
Interest Income/Expense
0.095
- - - -
Operating Income/Loss
20.65%
-26.86
-22.27 -23.11 -26.84 -32.03
Nonoperating Income/Loss
32.66%
2.559
1.929 2.134 2.214 1.96
Income/Loss From Continuing Operations Before Tax
19.51%
-24.30
-20.34 -20.98 -24.63 -30.07
Income Tax Expense/Benefit
-
- - - -
Income/Loss From Continuing Operations After Tax
19.51%
-24.30
-20.34 -20.98 -24.63 -30.07
Net Income/Loss
19.51%
-24.30
-20.34 -20.98 -24.63 -30.07
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
32,558%
38.16
0.1168 20.06 19.66 19.57
Diluted Average Shares
32,558%
38.16
0.1168 20.06 19.66 19.57
Basic Earnings Per Share
36.00%
-0.64
-1.00 -1.05 -1.25 -1.54
Diluted Earnings Per Share
36.00%
-0.64
-1.00 -1.05 -1.25 -1.54
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$17.87
price down icon 2.88%
$68.84
price up icon 2.65%
$39.39
price down icon 0.43%
$359.58
price down icon 0.16%
$176.50
price up icon 1.02%
$113.08
price up icon 1.56%
Kapitalisierung:     |  Volumen (24h):